| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institut de Pharmacologie et de Biologie Structurale du CNRS, 205 Route de Narbonne, 31077 Toulouse Cedex 4, France; and
* Commissariat à l’Energie atomique, Biochimie des Régulations Cellulaires Endocrines, INSERM U244 CEN/Grenoble, F-38054 Grenoble Cedex 9, France
1Correspondence: Institut de Pharmacologie et de Biologie Structurale du CNRS, 205 Route de Narbonne, 31077 Toulouse Cedex 4, France. E-mail: bouche{at}ipbs.fr
FGF-2 exerts its pleiotropic effects on cell growth and differentiation by interacting with specific cell surface receptors. In addition, exogenously added FGF-2 is translocated from outside the cell to the nucleus during G1-S transition. In this study, we show that a single point mutation in FGF-2 (substitution of residue serine 117 by alanine) is sufficient to drastically reduce its mitogenic activity without affecting its differentiation properties. The FGF-2(S117A) mutant binds to and activates tyrosine kinase receptors and induces MAPK and p70S6K activation as strongly as the wild-type FGF-2. We demonstrate that this mutant enters NIH3T3 cells, is translocated to the nucleus, and is phosphorylated similar to the wild-type growth factor. This suggests that FGF-2 mitogenic activity may require, in addition to signaling through cell surface receptors and nuclear translocation, activation of nuclear targets. We have previously shown that, in vitro, FGF-2 directly stimulates the activity of the casein kinase 2 (CK2), a ubiquitous serine/threonine kinase involved in the control of cell proliferation. We report that, in vivo, FGF-2(WT) transiently interacts with CK2 and stimulates its activity in the nucleus during G1-S transition in NIH3T3 cells. In contrast, the FGF-2(S117A) mutant fails to interact with CK2. Thus, our results show that FGF-2 mitogenic and differentiation activities can be dissociated by a single point mutation and that CK2 may be a new nuclear effector involved in FGF-2 mitogenic activity.—Bailly, K., Soulet, F., Leroy, D., Amalric, F., Bouche, G. Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor (FGF-2).
Key Words: FGF-2 • mitogenicity • signaling pathway • activation • CK2
This article has been cited by other articles:
|
|
 |
|
  M. J. Go, C. Takenaka, and H. Ohgushi Effect of Forced Expression of Basic Fibroblast Growth Factor in Human Bone Marrow-Derived Mesenchymal Stromal Cells J. Biochem., December 1, 2007; 142(6): 741 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Dupree, S. R. Pollack, E. M. Levine, and C. T. Laurencin Fibroblast Growth Factor 2 Induced Proliferation in Osteoblasts and Bone Marrow Stromal Cells: A Whole Cell Model Biophys. J., October 15, 2006; 91(8): 3097 - 3112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wesche, J. Malecki, A. Wiedlocha, C. S. Skjerpen, P. Claus, and S. Olsnes FGF-1 and FGF-2 Require the Cytosolic Chaperone Hsp90 for Translocation into the Cytosol and the Cell Nucleus J. Biol. Chem., April 21, 2006; 281(16): 11405 - 11412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Joliot Transduction Peptides Within Naturally Occurring Proteins Sci. Signal., December 6, 2005; 2005(313): pe54 - pe54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Sheng, Y. Liang, C.-Y. Lin, L. Comai, and W. J. Chirico Direct Regulation of rRNA Transcription by Fibroblast Growth Factor 2 Mol. Cell. Biol., November 1, 2005; 25(21): 9419 - 9426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Soulet, K. Bailly, S. Roga, A.-C. Lavigne, F. Amalric, and G. Bouche Exogenously Added Fibroblast Growth Factor 2 (FGF-2) to NIH3T3 Cells Interacts with Nuclear Ribosomal S6 Kinase 2 (RSK2) in a Cell Cycle-dependent Manner J. Biol. Chem., July 8, 2005; 280(27): 25604 - 25610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Ljubimov, S. Caballero, A. M. Aoki, L. A. Pinna, M. B. Grant, and R. Castellon Involvement of Protein Kinase CK2 in Angiogenesis and Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4583 - 4591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Sheng, J. A. Lewis, and W. J. Chirico Nuclear and Nucleolar Localization of 18-kDa Fibroblast Growth Factor-2 Is Controlled by C-terminal Signals J. Biol. Chem., September 17, 2004; 279(38): 40153 - 40160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kardami, Z.-S. Jiang, S. K Jimenez, C. J Hirst, F. Sheikh, P. Zahradka, and P. A Cattini Fibroblast growth factor 2 isoforms and cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 458 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Park, H.-S. Kim, H.-M. Yang, K.-W. Park, S.-W. Youn, S.-I. Jeon, D.-H. Kim, B.-K. Koo, I.-H. Chae, D.-J. Choi, et al. Thalidomide as a Potent Inhibitor of Neointimal Hyperplasia After Balloon Injury in Rat Carotid Artery Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 885 - 891. [Abstract] [Full Text]
|
|
|
|
|
|
Z.-S. Jiang, W. Srisakuldee, F. Soulet, G. Bouche, and E. Kardami Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion Cardiovasc Res, April 1, 2004; 62(1): 154 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Malecki, J. Wesche, C. S. Skjerpen, A. Wiedlocha, and S. Olsnes Translocation of FGF-1 and FGF-2 across Vesicular Membranes Occurs during G1-Phase by a Common Mechanism Mol. Biol. Cell, February 1, 2004; 15(2): 801 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Filhol, A. Nueda, V. Martel, D. Gerber-Scokaert, M. J. Benitez, C. Souchier, Y. Saoudi, and C. Cochet Live-Cell Fluorescence Imaging Reveals the Dynamics of Protein Kinase CK2 Individual Subunits Mol. Cell. Biol., February 1, 2003; 23(3): 975 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Olsnes, O. Klingenberg, and A. Wiedlocha Transport of Exogenous Growth Factors and Cytokines to the Cytosol and to the Nucleus Physiol Rev, January 1, 2003; 83(1): 163 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Gotlieb, A. Rosenthal, and P. Kazemian Fibroblast growth factor 2 regulation of mitral valve interstitial cell repair in vitro J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Skjerpen, J. Wesche, and S. Olsnes Identification of Ribosome-binding Protein p34 as an Intracellular Protein That Binds Acidic Fibroblast Growth Factor J. Biol. Chem., June 21, 2002; 277(26): 23864 - 23871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kishima, H. Yamamoto, Y. Izumoto, K. Yoshida, H. Enomoto, M. Yamamoto, T. Kuroda, H. Ito, K. Yoshizaki, and H. Nakamura Hepatoma-derived Growth Factor Stimulates Cell Growth after Translocation to the Nucleus by Nuclear Localization Signals J. Biol. Chem., March 15, 2002; 277(12): 10315 - 10322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tassi, A. Al-Attar, A. Aigner, M. R. Swift, K. McDonnell, A. Karavanov, and A. Wellstein Enhancement of Fibroblast Growth Factor (FGF) Activity by an FGF-binding Protein J. Biol. Chem., October 19, 2001; 276(43): 40247 - 40253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Van den Berghe, H. Laurell, I. Huez, C. Zanibellato, H. Prats, and B. Bugler FIF [Fibroblast Growth Factor-2 (FGF-2)-Interacting-Factor], a Nuclear Putatively Antiapoptotic Factor, Interacts Specifically with FGF-2 Mol. Endocrinol., November 1, 2000; 14(11): 1709 - 1724. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
